Literature DB >> 14521613

Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study.

I Juhan-Vague, P E Morange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14521613     DOI： 10.1046/j.1538-7836.2003.00398.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.

Authors:  Nabil ElDanasori; Nelly Abulata; Iman A Shaheen; Alaa M ElGendy; Waleed El-Khayat
Journal:  Clin Appl Thromb Hemost       Date:  2017-02-22       Impact factor: 2.389

2.  A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels.

Authors:  Maria Sabater-Lleal; Alfonso Buil; Juan Carlos Souto; Laura Alamsy; Montserrat Borrell; Mark Lathrop; John Blangero; Jordi Fontcuberta; José Manuel Soria
Journal:  Hum Genet       Date:  2008-06-18       Impact factor: 4.132

Review 3.  Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Authors:  Karen Claesen; Joachim C Mertens; Dorien Leenaerts; Dirk Hendriks
Journal:  Int J Mol Sci       Date:  2021-01-17       Impact factor: 5.923

4.  Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.

Authors:  András Kovács; László Szabó; Colin Longstaff; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2013-09-21       Impact factor: 3.944
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.